From vaccine hesitancy to vaccine motivation: A motivational interviewing based approach to vaccine counselling.
Humans
Motivational Interviewing
/ methods
COVID-19 Vaccines
/ administration & dosage
COVID-19
/ prevention & control
Health Personnel
/ psychology
Vaccination Hesitancy
/ psychology
Motivation
Vaccination
/ psychology
Counseling
/ methods
Decision Making
SARS-CoV-2
Health Knowledge, Attitudes, Practice
Motivational interviewing
counseling
healthcare providers
vaccine
vaccine hesitancy
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
31 Dec 2024
31 Dec 2024
Historique:
medline:
27
8
2024
pubmed:
27
8
2024
entrez:
26
8
2024
Statut:
ppublish
Résumé
The COVID-19 pandemic highlighted Vaccine Hesitancy (VH) as an accelerating global phenomenon that must be addressed. According to the WHO, thirty to fifty percent of the world's population are VH. Motivational Interviewing (MI) is an evidence-based communication style demonstrated to significantly reduce VH. MI guides people toward change through the expression of empathy and by respecting an individual's autonomy. Healthcare providers (HCPs) are the primary implementors of vaccine policies and the most trusted advisors and influencers of vaccination intention at the individual patient level. Training HCPs in MI is one of the most effective strategies to overcome VH. Many countries are currently implementing HCP training programs and population-based MI interventions to improve vaccine uptake. MI conversations are 'the heart' of vaccine decision-making processes. Understanding individual patient-level drivers of hesitancy allows clinicians to efficiently provide tailored, accurate information that reinforces a person's own motivation and confidence in their own decision. This paper describes a 4-step practical framework designed to support HCPs in their dialogue with vaccine-hesitant patients. (1)
Identifiants
pubmed: 39187772
doi: 10.1080/21645515.2024.2391625
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM